David Gaiero
Direttore Finanziario/CFO presso CYTEIR THERAPEUTICS, INC.
Posizioni attive di David Gaiero
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/12/2020 | - |
| Treasurer | 16/03/2022 | - | |
| IMUNON, INC. | Comptroller/Controller/Auditor | 01/06/2024 | - |
| Direttore Finanziario/CFO | 01/06/2024 | - | |
| Monomoy Advisors LLC | Corporate Officer/Principal | - | - |
Storia della carriera di David Gaiero
Precedenti posizioni note di David Gaiero
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| WAVE LIFE SCIENCES LTD. | Comptroller/Controller/Auditor | 01/07/2017 | 04/12/2020 |
| Direttore Finanziario/CFO | 09/01/2020 | 04/12/2020 | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | 01/01/2015 | 01/01/2017 |
Formazione di David Gaiero
| University of Massachusetts | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Singapore | 2 |
Posizioni
| Comptroller/Controller/Auditor | 3 |
| Director of Finance/CFO | 3 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| WAVE LIFE SCIENCES LTD. | Health Technology |
| IMUNON, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Monomoy Advisors LLC |
- Borsa valori
- Insiders
- David Gaiero
- Esperienza
